Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 251Magnetic Resonance Spectroscopy 246Cyclophosphamide 240Cisplatin 214Paclitaxel 205Radiotherapy 196Biopsy 172Gemcitabine 155Dexamethasone 150durvalumab 144atezolizumab 125Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 113Radiation 110Pemetrexed 101Etoposide 101Docetaxel 101fludarabine 97venetoclax 95Capecitabine 92Fluorouracil 91Radiosurgery 90Prednisone 89Oxaliplatin 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Dutasteride × 1 year × Clear all
NCT01653925 2025-11-24

Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression

CHU de Quebec-Universite Laval

Phase NA Active not recruiting
120 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡